pubmed-article:2129437 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2129437 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:2129437 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:2129437 | lifeskim:mentions | umls-concept:C0019004 | lld:lifeskim |
pubmed-article:2129437 | lifeskim:mentions | umls-concept:C1524112 | lld:lifeskim |
pubmed-article:2129437 | lifeskim:mentions | umls-concept:C0014822 | lld:lifeskim |
pubmed-article:2129437 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:2129437 | lifeskim:mentions | umls-concept:C1947976 | lld:lifeskim |
pubmed-article:2129437 | pubmed:dateCreated | 1991-10-7 | lld:pubmed |
pubmed-article:2129437 | pubmed:abstractText | To evaluate the acute and long-term haemodynamic response to recombinant human erythropoietin (rHuEpo) correction of chronic anaemia in haemodialysis-supported patients. | lld:pubmed |
pubmed-article:2129437 | pubmed:language | eng | lld:pubmed |
pubmed-article:2129437 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2129437 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2129437 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2129437 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2129437 | pubmed:issn | 0931-0509 | lld:pubmed |
pubmed-article:2129437 | pubmed:author | pubmed-author:ThomasTT | lld:pubmed |
pubmed-article:2129437 | pubmed:author | pubmed-author:BravoE LEL | lld:pubmed |
pubmed-article:2129437 | pubmed:author | pubmed-author:PaganiniE PEP | lld:pubmed |
pubmed-article:2129437 | pubmed:author | pubmed-author:Fouad-TaraziF... | lld:pubmed |
pubmed-article:2129437 | pubmed:author | pubmed-author:AbdulhadiM... | lld:pubmed |
pubmed-article:2129437 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2129437 | pubmed:volume | 5 Suppl 1 | lld:pubmed |
pubmed-article:2129437 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2129437 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2129437 | pubmed:pagination | 102-8 | lld:pubmed |
pubmed-article:2129437 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
pubmed-article:2129437 | pubmed:meshHeading | pubmed-meshheading:2129437-... | lld:pubmed |
pubmed-article:2129437 | pubmed:meshHeading | pubmed-meshheading:2129437-... | lld:pubmed |
pubmed-article:2129437 | pubmed:meshHeading | pubmed-meshheading:2129437-... | lld:pubmed |
pubmed-article:2129437 | pubmed:meshHeading | pubmed-meshheading:2129437-... | lld:pubmed |
pubmed-article:2129437 | pubmed:meshHeading | pubmed-meshheading:2129437-... | lld:pubmed |
pubmed-article:2129437 | pubmed:meshHeading | pubmed-meshheading:2129437-... | lld:pubmed |
pubmed-article:2129437 | pubmed:meshHeading | pubmed-meshheading:2129437-... | lld:pubmed |
pubmed-article:2129437 | pubmed:meshHeading | pubmed-meshheading:2129437-... | lld:pubmed |
pubmed-article:2129437 | pubmed:meshHeading | pubmed-meshheading:2129437-... | lld:pubmed |
pubmed-article:2129437 | pubmed:meshHeading | pubmed-meshheading:2129437-... | lld:pubmed |
pubmed-article:2129437 | pubmed:meshHeading | pubmed-meshheading:2129437-... | lld:pubmed |
pubmed-article:2129437 | pubmed:meshHeading | pubmed-meshheading:2129437-... | lld:pubmed |
pubmed-article:2129437 | pubmed:meshHeading | pubmed-meshheading:2129437-... | lld:pubmed |
pubmed-article:2129437 | pubmed:year | 1990 | lld:pubmed |
pubmed-article:2129437 | pubmed:articleTitle | The haemodynamic effects of correction of anaemia in haemodialysis patients using recombinant human erythropoietin. | lld:pubmed |
pubmed-article:2129437 | pubmed:affiliation | Department of Hypertension, Cleveland Clinic Foundation, Ohio. | lld:pubmed |
pubmed-article:2129437 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:2129437 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:2129437 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:2129437 | pubmed:publicationType | Multicenter Study | lld:pubmed |